Latest Asx Listings News

Vinyl Group grew FY26 revenue by 31% and nearly halved its net loss, but auditors flagged a material uncertainty over the company’s ability to continue as a going concern. The ASX-listed media group is now relying on acquisition-led growth, higher margins and possible future funding to reach profitability.

Pan African Resources delivered record FY26 production, earnings and cash generation, moving from net debt to a US$185.7 million net cash position. The gold producer is proposing a record dividend and launching a ZAR500 million buy-back, while warning that FY27 costs will rise as it funds further growth.

Cambium Bio has secured firm commitments for a conditional A$7.1 million placement, taking its proposed funding package to A$10.85 million for the pivotal Elate Ocular Phase 3 program. Completion depends on three inter-conditional shareholder resolutions at the company’s expected November AGM.

NoviqTech is seeking shareholder approval to acquire software and source code used by its Carbon Central and Fuel Central platforms from an entity associated with former director Freddy El Turk. Until the vote, the company has only an interim licence, creating a clear continuity risk if approval is not secured.

ION Video has secured an oversubscribed $4.25 million placement to fund independent trials of its video technology, with directors and management committing a further $1.2 million subject to shareholder approval. The capital will be used to test whether ION’s architecture can deliver measurable technical and financial benefits in real operating environments.

Rivco Australia has outlined a long-term water scarcity thesis, a 61 GL portfolio concentrated in the southern Murray-Darling Basin and a revised dividend framework beginning in 2027. The ASX-listed water investor says future dividends will be anchored more heavily to operating earnings rather than realised capital gains.

Avenira has agreed to supply Hebang with 500,000 wet metric tonnes of Wonarah phosphate rock annually for four years, covering more than 80% of expected DSO production. The commercial opportunity is substantial, but pricing, approvals and project arrangements remain unresolved.

Elixir Energy says its Lorelle-3H well reached a peak test rate of 10.5 MMscfd and a stable rate of 2.35 MMscfd during first-phase cleanup. The ASX-listed gas explorer is now preparing for post-soak testing while weighing farm-outs, joint ventures and other structures for its Taroom Trough assets.

Daly Resources ended FY2026 with $11.05 million in cash after its $12 million IPO, but reported a $3.63 million loss dominated by share-based remuneration. The ASX-listed explorer has no defined mineral resources or ore reserves and must now convert its exploration portfolio into results.

Franklin Templeton Australia is reshaping the FRGG Active ETF, replacing its concentrated global growth strategy with Putnam’s broader core equity approach and cutting management fees by one-third. The fund is expected to adopt the ticker FTPG in October, subject to approval, but the transition may bring tax and distribution consequences for investors.

Prescient Therapeutics has extended its Share Purchase Plan by three days after shareholders reported delays receiving application documents. The revised timetable places the offer’s results announcement just ahead of a planned briefing on the company’s PTX-100 development program.

PolyNovo delivered 16.1% revenue growth and a sharp improvement in operating cash flow in FY26, despite a lower statutory profit after a prior-year tax benefit and a fire-related write-off. The ASX-listed wound-care company now expects to lodge its U.S. PMA application for NovoSorb BTM before the end of 2026.